Total Funding
70
Total FundingConvertible Note raised
Growth Score
pts
Heat Score
-3 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
325305
SpectraGenetics is a developer of fluorogenic activating peptide intended to develop therapeutic proteins.
- G. Reid Asbury: Chief Executive Officer
About the Company
SpectraGenetics is a GPCR Company with proprietary technology for the direct measurement of GPCR internalization, trafficking and recylcling back to the cell membrane. This technology does not rely on secondary messengers or require imaging. It is based on Fluorogen Activating Peptide (FAP) technology originally developed at Carnegie Mellon
University. The company has tagged more than 150 GPCRs and has validated more than 30 cell lines.
Women Founded
